MyelinZ
AI-powered brain monitoring & rehabilitation
Manchester, UK
MyelinZ is a neurotechnology company developing AI-powered brain health and cognitive enhancement solutions. It positions itself as a science-led wellness platform inspired by clinical neuroscience rather than a medical device, and is named after myelin, the brain's insulation essential for memory, movement, and signal transmission.
Source: HealthTechAlpha
HealthTechAlpha provided this information. To learn more and get deep data on all digital health companies, please visit them here.
Visit HealthTechAlpha →Problem Statement
MyelinZ aims to make the invisible visible early by detecting cognitive changes before they become problematic, revolutionizing brain health for both terrestrial and space applications, and addressing cognitive, mental, and physical challenges.
Core Technology
AI-powered brain health and cognitive enhancement solutions
Key Differentiators
science-led wellness platform inspired by clinical neuroscience rather than a medical device
Clinical Focus
Neurology; Rehabilitation
Company Info
- Business Model
- Hybrid
- Total Funding
- 333,000
- Website
- myelinz.com
Clinical & IP
Clinical Validation
R-MMS multi-center Phase 2 trial (150+ MS patients, 7 countries) measuring disease progression detection, treatment response, relapse prediction. BodyMirror: consumer BCI launching Sept 2025. AI model demonstrates 93% accuracy in lesion detection vs 58% standard radiology.
MedStartr Index Score
?What do you think of MyelinZ?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.